RFK Jr. Advocates for Lifting FDA Ban on Controversial Peptide Treatments
RFK Jr. wants Americans to use peptides that were banned over safety risks
Ars Technica
Image: Ars Technica
Robert F. Kennedy Jr., a prominent anti-vaccine advocate, is urging the U.S. Food and Drug Administration (FDA) to lift restrictions on over a dozen injectable peptide treatments that were previously banned due to safety concerns. These unproven peptides have gained popularity among wellness influencers despite lacking efficacy data.
- 01Robert F. Kennedy Jr. is pushing for the FDA to lift bans on injectable peptides.
- 02These peptides were previously banned due to significant safety risks.
- 03Kennedy claims to have used these peptides effectively for injury treatment.
- 04The FDA reclassified these peptides in 2023, limiting their availability.
- 05Black and gray markets continue to sell these unproven peptide products.
Advertisement
In-Article Ad
Robert F. Kennedy Jr. (anti-vaccine activist) is advocating for the U.S. Food and Drug Administration (FDA) to remove restrictions on over a dozen injectable peptide treatments, which were banned due to safety risks. Peptides are chains of amino acids that can influence various biochemical processes, but the specific treatments Kennedy supports lack substantial efficacy data. On February 27, during an appearance on Joe Rogan's podcast, he expressed his support for these unproven treatments, claiming personal success in using them for injuries. The FDA's 2023 decision to reclassify these peptides stemmed from concerns about their safety and the rise of unverified claims regarding their benefits. As a result, compounding pharmacies can no longer produce these peptides for human use, although they remain available through black and gray markets, some of which are linked to Kennedy's supporters. This situation raises concerns about the safety and regulation of peptide treatments in the wellness industry.
Advertisement
In-Article Ad
If the FDA lifts the ban, it could lead to increased availability of unproven peptide treatments, raising concerns about public health and safety.
Advertisement
In-Article Ad
More about U.S. Food and Drug Administration
Trump Administration Threatens 100% Tariff on Imported Pharmaceuticals to Boost Domestic Production
The Economic Times • Apr 3, 2026

US Company Recalls Chocolate Products Contaminated with Erectile Dysfunction Drugs
Ndtv • Apr 2, 2026

FDA to Reclassify Peptides: Implications for Skin Care and Beyond
Ndtv • Apr 1, 2026
Read the original article
Visit the source for the complete story.




